651 related articles for article (PubMed ID: 20931366)
1. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
2. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
3. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells.
Kahook MY; Ammar DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):259-63. PubMed ID: 20565312
[TBL] [Abstract][Full Text] [Related]
4. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
5. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
Ammar DA; Kahook MY
Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
7. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
10. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
Kahook MY; Noecker R
Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
[TBL] [Abstract][Full Text] [Related]
14. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
Whitson JT; Petroll WM
Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
[TBL] [Abstract][Full Text] [Related]
15. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
16. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Ammar DA; Kahook MY
Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
[TBL] [Abstract][Full Text] [Related]
19. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5154-60. PubMed ID: 22695966
[TBL] [Abstract][Full Text] [Related]
20. Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study.
Aihara M; Oshima H; Araie M;
Acta Ophthalmol; 2013 Feb; 91(1):e7-e14. PubMed ID: 23241328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
